5-AMINO 10MG

5-Amino-1MQ is a small molecule (not actually a peptide, unlike most of the others in this conversation) that’s marketed as an inhibitor of NNMT — nicotinamide N-methyltransferase, an enzyme involved in cellular energy metabolism.

Research background:

• Preclinical research (primarily in cell cultures and animal models) suggests inhibiting NNMT may increase cellular NAD+ and SAM (S-adenosylmethionine) levels, which are involved in energy metabolism and could theoretically affect fat cell formation and function.

• It’s been studied in the context of obesity and metabolic research — some animal studies show reduced fat mass or improved metabolic markers.

• There is very limited to no published human clinical trial data on 5-Amino-1MQ specifically. Most of what circulates online is extrapolated from rodent studies or from general NNMT-pathway research, not from trials in people.

Important caveats:

• It’s not FDA-approved for any use and is sold as a research chemical, typically labeled “not for human consumption.”

• Long-term safety, appropriate human dosing, and interaction effects are essentially unknown — this is an earlier-stage, less-studied compound than even some of the peptides discussed above.

• Marketing claims around “fat loss” or “anti-aging” in humans significantly outpace the actual evidence, which is mostly preclinical/animal-stage.